首页 > 最新文献

Archives of Iranian Medicine最新文献

英文 中文
The Gap Between the Actual Cost and Tariffs of Global Surgical Procedures: A Retrospective Cross-sectional Study in Qazvin Province, Iran. 全球外科手术实际成本与关税之间的差距:伊朗加兹温省的回顾性横断面研究。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.34172/aim.31106
Ehsan Zarei, Maedehsadat Hashemi, Pouria Farrokhi

Background: Iran's healthcare system has a significant discrepancy between the national tariff and the cost of global surgical procedures (GSPs). This study aimed to compare the actual costs of GSPs with national tariffs in Iran's public hospitals.

Methods: This retrospective cross-sectional study was conducted in 2017. Using the census method, 6126 GSPs performed in three public hospitals were investigated in this study. Additionally, national tariffs from the Supreme Council of Health Insurance were obtained. The tariff-cost gap was the discrepancy between a GSP's actual costs and tariff. Multiple linear regression analysis determined factors affecting the tariff-cost gap.

Results: The average actual cost of GSPs was 637 USD, while the average tariff was 495 USD. The reimbursement covered only 78% of the costs. The gap was higher in older (B=1.05, 95% CI: 0.76-1.35, P<0.001), females (B=26.7, 95% CI: 15.5-37.9, P<0.001), patients with a longer stay (B=81.2, 95% CI: 77.5-84.8, P<0.001), and procedures performed by full-time surgeons (B=67.3, 95% CI: 56.9-77.5, P<0.001). Furthermore, neurosurgery had the highest effect on forecasting the gap between actual costs and tariffs among surgical specialties (B=346.9, 95% CI: 214.3-479.5, P<0.001).

Conclusion: Public hospitals suffer from large financial losses due to the national tariff for many GSPs not covering their actual costs. It is suggested that tariffs be increased for certain customer segments that can bear higher costs and global tariffs be adjusted to match actual service delivery costs.

背景:伊朗医疗系统的国家收费标准与全球外科手术(GSP)的成本之间存在巨大差异。本研究旨在比较伊朗公立医院 GSP 的实际成本与国家收费标准:这项回顾性横断面研究于 2017 年进行。本研究采用普查方法,对三家公立医院的 6126 例 GSP 进行了调查。此外,还从最高医疗保险委员会获得了国家收费标准。关税-成本差距是指 GSP 的实际成本与关税之间的差异。多元线性回归分析确定了影响关税-成本差距的因素:GSP 的平均实际成本为 637 美元,而平均关税为 495 美元。报销费用仅占成本的 78%。老年患者的差距更大(B=1.05,95% CI:0.76-1.35,购买力平价):由于许多 GSP 的国家收费标准无法覆盖实际成本,公立医院蒙受了巨大的经济损失。建议对某些能够承担较高成本的客户群提高收费标准,并调整全球收费标准,使其与实际服务成本相匹配。
{"title":"The Gap Between the Actual Cost and Tariffs of Global Surgical Procedures: A Retrospective Cross-sectional Study in Qazvin Province, Iran.","authors":"Ehsan Zarei, Maedehsadat Hashemi, Pouria Farrokhi","doi":"10.34172/aim.31106","DOIUrl":"10.34172/aim.31106","url":null,"abstract":"<p><strong>Background: </strong>Iran's healthcare system has a significant discrepancy between the national tariff and the cost of global surgical procedures (GSPs). This study aimed to compare the actual costs of GSPs with national tariffs in Iran's public hospitals.</p><p><strong>Methods: </strong>This retrospective cross-sectional study was conducted in 2017. Using the census method, 6126 GSPs performed in three public hospitals were investigated in this study. Additionally, national tariffs from the Supreme Council of Health Insurance were obtained. The tariff-cost gap was the discrepancy between a GSP's actual costs and tariff. Multiple linear regression analysis determined factors affecting the tariff-cost gap.</p><p><strong>Results: </strong>The average actual cost of GSPs was 637 USD, while the average tariff was 495 USD. The reimbursement covered only 78% of the costs. The gap was higher in older (B=1.05, 95% CI: 0.76-1.35, <i>P</i><0.001), females (B=26.7, 95% CI: 15.5-37.9, <i>P</i><0.001), patients with a longer stay (B=81.2, 95% CI: 77.5-84.8, <i>P</i><0.001), and procedures performed by full-time surgeons (B=67.3, 95% CI: 56.9-77.5, <i>P</i><0.001). Furthermore, neurosurgery had the highest effect on forecasting the gap between actual costs and tariffs among surgical specialties (B=346.9, 95% CI: 214.3-479.5, <i>P</i><0.001).</p><p><strong>Conclusion: </strong>Public hospitals suffer from large financial losses due to the national tariff for many GSPs not covering their actual costs. It is suggested that tariffs be increased for certain customer segments that can bear higher costs and global tariffs be adjusted to match actual service delivery costs.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"27 10","pages":"580-587"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532652/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global Research Trends on Colorectal Cancer (2014-2023): A Scientometric and Visualized Study. 全球结直肠癌研究趋势(2014-2023 年):科学计量与可视化研究。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.34172/aim.31944
Iman Menbari Oskouie, Hediyeh Alemi, Naghmeh Khavandgar, Heydar Ali Mardani-Fard, Azadeh AleTaha, Amir-Hossein Mousavian, Ali Rahimi, Mohammad Abdollahi, Akbar Soltani, Amir Kasaeian, Majid Sorouri

Background: Colorectal cancer (CRC) ranks as the third most common cancer worldwide, significantly contributing to cancer-related deaths and increasingly affecting younger populations. Although its impact on patients' quality of life is profound, scientometric studies on CRC remain underexplored. The objective of this study was to evaluate the scientific literature on CRC from 2014 to 2023, employing a range of scientometric and statistical approaches.

Methods: This study obtained CRC-related publications from the Scopus database. The analyses of the collaboration and co-occurrence among countries/regions, institutions, journals, references, authors, and keywords were conducted utilizing VOSviewer, facilitating the identification of key research trends and emergent subjects.

Results: A review of Scopus entries yielded 200,385 papers on CRC in the last decade, noting a yearly increase in publications from 2014 to 2023. China emerged as the most prolific contributor with 46,674 documents. A positive correlation was identified between a country's CRC research output and gross domestic product (GDP; r=0.961, P<0.001). The journal "Cancers" led to 3006 articles, and H. Brenner stood out as the foremost author with 452 publications. However, the Ministry of Education of the People's Republic of China led institutional contributions to 3094 papers.

Conclusion: With a leading count of 46674 articles, China dominated CRC research, particularly highlighted by the Ministry of Education of the People's Republic of China. The primarily obtained keywords were CRC, cancer, prognosis, rectal cancer, and colon cancer. Despite the presence of global collaborations, there is a pressing need for increased research funding and support in the CRC, especially within developing nations. This study is a navigational tool for medical professionals, researchers, and surgical assistants to grasp the international progress and directions in CRC research.

背景:结肠直肠癌(CRC)是全球第三大常见癌症,是导致癌症相关死亡的重要原因,而且越来越多地影响着年轻人群。虽然它对患者的生活质量影响深远,但有关 CRC 的科学计量学研究仍然不足。本研究旨在采用一系列科学计量学和统计学方法,评估 2014 年至 2023 年有关 CRC 的科学文献:本研究从 Scopus 数据库中获取了与 CRC 相关的出版物。利用 VOSviewer 对国家/地区、机构、期刊、参考文献、作者和关键词之间的合作与共现进行了分析,从而有助于确定关键的研究趋势和新出现的主题:对 Scopus 的条目进行审查后发现,在过去十年中,有关 CRC 的论文有 200,385 篇,从 2014 年到 2023 年,论文数量逐年增加。中国的论文数量最多,达到 46 674 篇。研究发现,一个国家的 CRC 研究成果与国内生产总值(GDP;r=0.961,PConclusion)之间存在正相关关系:中国在 CRC 研究中占据主导地位,发表了 46674 篇文章,中华人民共和国教育部的研究成果尤为突出。获得的主要关键词是 CRC、癌症、预后、直肠癌和结肠癌。尽管存在全球合作,但仍迫切需要增加对 CRC 的研究经费和支持,尤其是在发展中国家。这项研究为医疗专业人员、研究人员和手术助手提供了一个导航工具,帮助他们掌握 CRC 研究的国际进展和方向。
{"title":"Global Research Trends on Colorectal Cancer (2014-2023): A Scientometric and Visualized Study.","authors":"Iman Menbari Oskouie, Hediyeh Alemi, Naghmeh Khavandgar, Heydar Ali Mardani-Fard, Azadeh AleTaha, Amir-Hossein Mousavian, Ali Rahimi, Mohammad Abdollahi, Akbar Soltani, Amir Kasaeian, Majid Sorouri","doi":"10.34172/aim.31944","DOIUrl":"10.34172/aim.31944","url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer (CRC) ranks as the third most common cancer worldwide, significantly contributing to cancer-related deaths and increasingly affecting younger populations. Although its impact on patients' quality of life is profound, scientometric studies on CRC remain underexplored. The objective of this study was to evaluate the scientific literature on CRC from 2014 to 2023, employing a range of scientometric and statistical approaches.</p><p><strong>Methods: </strong>This study obtained CRC-related publications from the Scopus database. The analyses of the collaboration and co-occurrence among countries/regions, institutions, journals, references, authors, and keywords were conducted utilizing VOSviewer, facilitating the identification of key research trends and emergent subjects.</p><p><strong>Results: </strong>A review of Scopus entries yielded 200,385 papers on CRC in the last decade, noting a yearly increase in publications from 2014 to 2023. China emerged as the most prolific contributor with 46,674 documents. A positive correlation was identified between a country's CRC research output and gross domestic product (GDP; <i>r</i>=0.961, <i>P</i><0.001). The journal \"Cancers\" led to 3006 articles, and H. Brenner stood out as the foremost author with 452 publications. However, the Ministry of Education of the People's Republic of China led institutional contributions to 3094 papers.</p><p><strong>Conclusion: </strong>With a leading count of 46674 articles, China dominated CRC research, particularly highlighted by the Ministry of Education of the People's Republic of China. The primarily obtained keywords were CRC, cancer, prognosis, rectal cancer, and colon cancer. Despite the presence of global collaborations, there is a pressing need for increased research funding and support in the CRC, especially within developing nations. This study is a navigational tool for medical professionals, researchers, and surgical assistants to grasp the international progress and directions in CRC research.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"27 10","pages":"563-572"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532657/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of Post-traumatic Stress Disorder in Iranian Population From 2019 to 2024: A Systematic Review and Meta-analysis. 2019年至2024年伊朗人口中创伤后应激障碍的流行病学:系统回顾与元分析》。
IF 16.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.34172/aim.31230
Asad Imani, Shahram Molavynejad, Mojgan Khademi, Mohammad Adineh, Elham Shafiei, Mohsen Savaie

Background: Post-traumatic stress disorder (PTSD) is a disorder that arises from experiencing traumatic events such as traffic accidents, war, natural disorders, and job incidents. This study focused on determining the epidemiology of PTSD in the Iranian population from 2019 to 2024.

Methods: In this systematic review and meta-analysis, we explored databases such as PubMed, Embase, Web of Knowledge, Scopus, and Magiran to achieve a maximum variety of screened articles. The quality of the included articles was evaluated using the STROBE checklist. For data analysis, due to the variation in reporting the PTSD prevalence across the reviewed articles, heterogeneity was assessed using the I2 index, and a random effect model was applied to account for this variation.

Results: Out of 800 articles found in the initial review, only 15 articles were entered in the final analysis based on inclusion and exclusion criteria, with a total of 9868 participants. The overall PTSD prevalence in the Iranian population was 31.87% (95% confidence interval [CI]=17.87- 45.87, I2=95.29%, P<0.001). Additionally, PTSD prevalence in men (36.64%) was higher than in women (35.52%).

Conclusion: The prevalence of PTSD in young Iranian men is relatively high, and there was no statistically significant decrease in PTSD prevalence between 2019 and 2024.

背景:创伤后应激障碍(PTSD创伤后应激障碍(PTSD)是一种因经历交通事故、战争、自然失调和工作事故等创伤事件而导致的障碍。本研究的重点是确定 2019 年至 2024 年伊朗人口中创伤后应激障碍的流行病学:在这项系统综述和荟萃分析中,我们搜索了 PubMed、Embase、Web of Knowledge、Scopus 和 Magiran 等数据库,以最大限度地筛选各种文章。我们使用 STROBE 检查表对纳入文章的质量进行了评估。在进行数据分析时,由于受检文章在报告创伤后应激障碍患病率方面存在差异,因此使用 I2 指数对异质性进行了评估,并采用随机效应模型来考虑这种差异:在初步审查的 800 篇文章中,根据纳入和排除标准,只有 15 篇文章被纳入最终分析,共有 9868 名参与者。伊朗人群中创伤后应激障碍的总体患病率为 31.87%(95% 置信区间 [CI]=17.87- 45.87,I2=95.29%,PConclusion):伊朗年轻男性的创伤后应激障碍患病率相对较高,2019 年至 2024 年期间,创伤后应激障碍患病率在统计学上没有显著下降。
{"title":"Epidemiology of Post-traumatic Stress Disorder in Iranian Population From 2019 to 2024: A Systematic Review and Meta-analysis.","authors":"Asad Imani, Shahram Molavynejad, Mojgan Khademi, Mohammad Adineh, Elham Shafiei, Mohsen Savaie","doi":"10.34172/aim.31230","DOIUrl":"10.34172/aim.31230","url":null,"abstract":"<p><strong>Background: </strong>Post-traumatic stress disorder (PTSD) is a disorder that arises from experiencing traumatic events such as traffic accidents, war, natural disorders, and job incidents. This study focused on determining the epidemiology of PTSD in the Iranian population from 2019 to 2024.</p><p><strong>Methods: </strong>In this systematic review and meta-analysis, we explored databases such as PubMed, Embase, Web of Knowledge, Scopus, and Magiran to achieve a maximum variety of screened articles. The quality of the included articles was evaluated using the STROBE checklist. For data analysis, due to the variation in reporting the PTSD prevalence across the reviewed articles, heterogeneity was assessed using the I<sup>2</sup> index, and a random effect model was applied to account for this variation.</p><p><strong>Results: </strong>Out of 800 articles found in the initial review, only 15 articles were entered in the final analysis based on inclusion and exclusion criteria, with a total of 9868 participants. The overall PTSD prevalence in the Iranian population was 31.87% (95% confidence interval [CI]=17.87- 45.87, I<sup>2</sup>=95.29%, <i>P</i><0.001). Additionally, PTSD prevalence in men (36.64%) was higher than in women (35.52%).</p><p><strong>Conclusion: </strong>The prevalence of PTSD in young Iranian men is relatively high, and there was no statistically significant decrease in PTSD prevalence between 2019 and 2024.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"27 10","pages":"588-594"},"PeriodicalIF":16.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532654/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine-Learning Application for Predicting Metabolic Dysfunction-Associated Steatotic Liver Disease Using Laboratory and Body Composition Indicators. 利用实验室指标和身体成分指标预测代谢功能障碍相关性脂肪肝的机器学习应用。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.34172/aim.31269
Fatemeh Masaebi, Mehdi Azizmohammad Looha, Morteza Mohammadzadeh, Vida Pahlevani, Mojtaba Farjam, Farid Zayeri, Reza Homayounfar

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a significant global health burden without established curative therapies. Early detection and preventive strategies are crucial for effective MASLD management. This study aimed to develop and validate machine-learning (ML) algorithms for accurate MASLD screening in a geographically diverse, large-scale population.

Methods: Data from the prospective Fasa Cohort Study, initiated in rural Fars province, Iran (March 2014), were employed for this purpose. The required data were collected using blood tests, questionnaires, liver ultrasonography, and physical examinations. A two-step approach identified key predictors from over 100 variables: (1) statistical selection using mean decrease Gini in random forest and (2) incorporation of clinical expertise for alignment with known MASLD risk factors. The hold-out validation approach (with a 70/30 train/validation split) was utilized, along with 5-fold cross-validation on the validation set. Logistic regression, Naïve Bayes, support vector machine, and light gradient-boosting machine (LightGBM) algorithms were compared for model construction with the same input variables based on area under the receiver operating characteristic curve (AUC), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy.

Results: A total of 6,180 adults (52.7% female) were included in the study, categorized into 4816 non-MASLD and 1364 MASLD cases with a mean age (±standard deviation [SD]) of 48.12 (±9.61) and 49.47 (±9.15) years, respectively. Logistic regression outperformed other ML algorithms, achieving an accuracy of 0.88 (95% confidence interval [CI]: 0.86-0.89) and an AUC of 0.92 (95% CI: 0.90-0.93). Among more than 100 variables, the key predictors included waist circumference, body mass index (BMI), hip circumference, wrist circumference, alanine aminotransferase levels, cholesterol, glucose, high-density lipoprotein, and blood pressure.

Conclusion: Integration of ML in MASLD management holds significant promise, particularly in resource-limited rural settings. Additionally, the relative importance assigned to each predictor, particularly prominent contributors such as waist circumference and BMI, offers valuable insights into MASLD prevention, diagnosis, and treatment strategies.

背景:代谢功能障碍相关性脂肪性肝病(MASLD)是一种严重的全球性健康负担,目前尚无成熟的治疗方法。早期检测和预防策略对于有效管理代谢性脂肪肝至关重要。本研究旨在开发和验证机器学习(ML)算法,以便在不同地域的大规模人群中进行准确的MASLD筛查:方法:本研究采用了在伊朗法尔斯省农村地区启动的前瞻性法萨队列研究(2014 年 3 月)的数据。所需数据是通过血液化验、问卷调查、肝脏超声波检查和体格检查收集的。采用两步法从 100 多个变量中确定关键预测因子:(1)使用随机森林中的平均下降基尼进行统计选择;(2)结合临床专业知识,与已知的 MASLD 风险因素进行比对。采用了保留验证方法(训练/验证比例为 70/30),并在验证集上进行了 5 倍交叉验证。根据接收者工作特征曲线下面积(AUC)、灵敏度、特异性、阳性预测值(PPV)、阴性预测值(NPV)和准确性,比较了逻辑回归、奈夫贝叶斯、支持向量机和轻梯度提升机(LightGBM)算法在相同输入变量下的模型构建:研究共纳入 6180 名成人(52.7% 为女性),分为 4816 个非 MASLD 病例和 1364 个 MASLD 病例,平均年龄(±标准差 [SD])分别为 48.12 岁(±9.61 岁)和 49.47 岁(±9.15 岁)。逻辑回归优于其他 ML 算法,准确率达到 0.88(95% 置信区间 [CI]:0.86-0.89),AUC 为 0.92(95% CI:0.90-0.93)。在 100 多个变量中,主要预测因素包括腰围、体重指数(BMI)、臀围、腕围、丙氨酸氨基转移酶水平、胆固醇、葡萄糖、高密度脂蛋白和血压:将 ML 纳入 MASLD 管理大有可为,尤其是在资源有限的农村地区。此外,每个预测因子的相对重要性,尤其是腰围和体重指数等突出的预测因子,为 MASLD 的预防、诊断和治疗策略提供了有价值的见解。
{"title":"Machine-Learning Application for Predicting Metabolic Dysfunction-Associated Steatotic Liver Disease Using Laboratory and Body Composition Indicators.","authors":"Fatemeh Masaebi, Mehdi Azizmohammad Looha, Morteza Mohammadzadeh, Vida Pahlevani, Mojtaba Farjam, Farid Zayeri, Reza Homayounfar","doi":"10.34172/aim.31269","DOIUrl":"10.34172/aim.31269","url":null,"abstract":"<p><strong>Background: </strong>Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a significant global health burden without established curative therapies. Early detection and preventive strategies are crucial for effective MASLD management. This study aimed to develop and validate machine-learning (ML) algorithms for accurate MASLD screening in a geographically diverse, large-scale population.</p><p><strong>Methods: </strong>Data from the prospective Fasa Cohort Study, initiated in rural Fars province, Iran (March 2014), were employed for this purpose. The required data were collected using blood tests, questionnaires, liver ultrasonography, and physical examinations. A two-step approach identified key predictors from over 100 variables: (1) statistical selection using mean decrease Gini in random forest and (2) incorporation of clinical expertise for alignment with known MASLD risk factors. The hold-out validation approach (with a 70/30 train/validation split) was utilized, along with 5-fold cross-validation on the validation set. Logistic regression, Naïve Bayes, support vector machine, and light gradient-boosting machine (LightGBM) algorithms were compared for model construction with the same input variables based on area under the receiver operating characteristic curve (AUC), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy.</p><p><strong>Results: </strong>A total of 6,180 adults (52.7% female) were included in the study, categorized into 4816 non-MASLD and 1364 MASLD cases with a mean age (±standard deviation [SD]) of 48.12 (±9.61) and 49.47 (±9.15) years, respectively. Logistic regression outperformed other ML algorithms, achieving an accuracy of 0.88 (95% confidence interval [CI]: 0.86-0.89) and an AUC of 0.92 (95% CI: 0.90-0.93). Among more than 100 variables, the key predictors included waist circumference, body mass index (BMI), hip circumference, wrist circumference, alanine aminotransferase levels, cholesterol, glucose, high-density lipoprotein, and blood pressure.</p><p><strong>Conclusion: </strong>Integration of ML in MASLD management holds significant promise, particularly in resource-limited rural settings. Additionally, the relative importance assigned to each predictor, particularly prominent contributors such as waist circumference and BMI, offers valuable insights into MASLD prevention, diagnosis, and treatment strategies.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"27 10","pages":"551-562"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532655/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventive Effects of a CVD Polypill on Developing Diabetes Among Patients With Metabolic Syndrome: Results of the PolyIran-Liver Trial. 心血管疾病多药对代谢综合征患者罹患糖尿病的预防作用:聚肝丸试验结果。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.34172/aim.31839
Elham Jafari, Hossein Poustchi, Abbas Mohagheghi, Maryam Sharafkhah, Masoud Khoshnia, Alireza Nateghi, Shahin Merat, Reza Malekzadeh

Background: While cardiovascular disease (CVD) polypills have demonstrated significant benefits in preventing CVD events by managing CVD risk factors and improving patient adherence, their effects on blood glucose levels, an important risk factor for CVD, remain unknown.

Methods: We analyzed data from the PolyIran-Liver trial, which involved 1,508 participants aged 50 and above. Of these, 787 were randomly assigned to receive a polypill (consisting of aspirin, atorvastatin, hydrochlorothiazide, and valsartan), while 721 received usual care as the control group over a five-year period. The aim was to determine whether there were any significant differences in fasting blood sugar (FBS) levels between the two groups at baseline, middle, and end of the study. The data analysis focused on three subgroups: participants with diabetes, those with metabolic syndrome (MetS) but without diabetes, and participants without diabetes or MetS.

Results: Of the total studied population, with a mean age of 59±6.7 years, 328(22%) were identified with diabetes, 371 (25%) with MetS but without diabetes, and 809 (54%) without diabetes or MetS. We observed a trend of rising FBS levels until month 30, followed by a subsequent decline at month 60. Participants in the polypill group exhibited lower FBS levels than the control group at both time points, with statistically significant differences in all three subgroups at month 30 and in the MetS-without diabetes at month 60 (mean difference: -9.3 mg/dl, 95% CI: 13.9 to -4.6).

Conclusion: The polypill used in this study may have the potential to delay the onset of diabetes in patients with MetS more effectively than in the general population. However, its beneficial effects on the blood sugar levels of diabetic individuals require further investigation.

背景:尽管心血管疾病(CVD)多糖丸通过控制心血管疾病风险因素和提高患者的依从性,在预防心血管疾病事件方面取得了显著疗效,但其对心血管疾病的重要风险因素--血糖水平的影响仍然未知:我们分析了 PolyIran-Liver 试验的数据,该试验涉及 1,508 名 50 岁及以上的参与者。其中,787 人被随机分配接受多潘立酮(由阿司匹林、阿托伐他汀、氢氯噻嗪和缬沙坦组成)治疗,721 人作为对照组接受为期五年的常规治疗。研究的目的是确定两组在基线、中期和末期的空腹血糖(FBS)水平是否存在显著差异。数据分析主要针对三个亚组:患有糖尿病的参与者、患有代谢综合征(MetS)但未患糖尿病的参与者以及未患糖尿病或代谢综合征的参与者:研究对象的平均年龄为 59±6.7 岁,其中 328 人(22%)患有糖尿病,371 人(25%)患有代谢综合征但未患糖尿病,809 人(54%)未患糖尿病或代谢综合征。我们观察到,FBS 水平在第 30 个月前呈上升趋势,随后在第 60 个月有所下降。多糖药丸组的参与者在两个时间点的 FBS 水平均低于对照组,在第 30 个月时,所有三个亚组的 FBS 水平均有显著统计学差异,在第 60 个月时,无糖尿病的 MetS 患者的 FBS 水平也有显著统计学差异(平均差异:-9.3 mg/dl,95% CI:13.9 至 -4.6):结论:与普通人群相比,本研究中使用的多丸类药物有可能更有效地延缓 MetS 患者糖尿病的发病。然而,它对糖尿病患者血糖水平的有益影响还需要进一步研究。
{"title":"Preventive Effects of a CVD Polypill on Developing Diabetes Among Patients With Metabolic Syndrome: Results of the PolyIran-Liver Trial.","authors":"Elham Jafari, Hossein Poustchi, Abbas Mohagheghi, Maryam Sharafkhah, Masoud Khoshnia, Alireza Nateghi, Shahin Merat, Reza Malekzadeh","doi":"10.34172/aim.31839","DOIUrl":"10.34172/aim.31839","url":null,"abstract":"<p><strong>Background: </strong>While cardiovascular disease (CVD) polypills have demonstrated significant benefits in preventing CVD events by managing CVD risk factors and improving patient adherence, their effects on blood glucose levels, an important risk factor for CVD, remain unknown.</p><p><strong>Methods: </strong>We analyzed data from the PolyIran-Liver trial, which involved 1,508 participants aged 50 and above. Of these, 787 were randomly assigned to receive a polypill (consisting of aspirin, atorvastatin, hydrochlorothiazide, and valsartan), while 721 received usual care as the control group over a five-year period. The aim was to determine whether there were any significant differences in fasting blood sugar (FBS) levels between the two groups at baseline, middle, and end of the study. The data analysis focused on three subgroups: participants with diabetes, those with metabolic syndrome (MetS) but without diabetes, and participants without diabetes or MetS.</p><p><strong>Results: </strong>Of the total studied population, with a mean age of 59±6.7 years, 328(22%) were identified with diabetes, 371 (25%) with MetS but without diabetes, and 809 (54%) without diabetes or MetS. We observed a trend of rising FBS levels until month 30, followed by a subsequent decline at month 60. Participants in the polypill group exhibited lower FBS levels than the control group at both time points, with statistically significant differences in all three subgroups at month 30 and in the MetS-without diabetes at month 60 (mean difference: -9.3 mg/dl, 95% CI: 13.9 to -4.6).</p><p><strong>Conclusion: </strong>The polypill used in this study may have the potential to delay the onset of diabetes in patients with MetS more effectively than in the general population. However, its beneficial effects on the blood sugar levels of diabetic individuals require further investigation.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"27 10","pages":"538-544"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532650/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discovery of Ornithodoros tholozani, the Main Vector of Iranian Tick-born Relapsing Fever. 发现伊朗蜱源性复发性热病的主要传播媒介 Ornithodoros tholozani。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.34172/aim.31196
Ali Emadzadeh, Shirin Taraz Jamshidi

Doctor Joseph Désiré Tholozan was a French physician who became the special physician of Nassereddin Shah, King of Persia (Iran) in the 19th century. He studied lots of topics in the field of epidemiology of infectious diseases. His efforts led to the discovery of the main vector of Iranian tick-born relapsing fever, Ornithodoros tholozani. He was also one of the pioneers of the Iranian Sanitary Council, whose efforts led to the foundation of the Ministry of Health of Iran a few decades later. This paper is a brief review of his biography and his roles in promoting health in Iran in the 19th century.

约瑟夫-德西雷-托洛赞医生是一位法国医生,19 世纪时曾担任波斯(伊朗)国王纳赛尔丁-沙阿的特约医生。他研究了传染病流行病学领域的许多课题。在他的努力下,发现了伊朗蜱传复发性热病的主要病媒 Ornithodoros tholozani。他还是伊朗卫生委员会的先驱之一,几十年后,伊朗卫生部就是在他的努力下成立的。本文简要回顾了他的生平及其在 19 世纪促进伊朗卫生事业方面所发挥的作用。
{"title":"Discovery of <i>Ornithodoros tholozani</i>, the Main Vector of Iranian Tick-born Relapsing Fever.","authors":"Ali Emadzadeh, Shirin Taraz Jamshidi","doi":"10.34172/aim.31196","DOIUrl":"10.34172/aim.31196","url":null,"abstract":"<p><p>Doctor Joseph Désiré Tholozan was a French physician who became the special physician of Nassereddin Shah, King of Persia (Iran) in the 19<sup>th</sup> century. He studied lots of topics in the field of epidemiology of infectious diseases. His efforts led to the discovery of the main vector of Iranian tick-born relapsing fever, <i>Ornithodoros tholozani</i>. He was also one of the pioneers of the Iranian Sanitary Council, whose efforts led to the foundation of the Ministry of Health of Iran a few decades later. This paper is a brief review of his biography and his roles in promoting health in Iran in the 19<sup>th</sup> century.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"27 10","pages":"595-597"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532656/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Congenital Anomalies in Iran. 伊朗先天性畸形的发病率。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.34172/aim.31287
Ahmad Khaleghnejad-Tabari, Saeed Dastgiri, Hamid Soori, Alireza Ansari-Moghaddam, Haleh Ghaem, Mahmoud Latifi, Mohammad Reza Maracy, Saeed Aslanabadi, Fathollah Roshanzamir, Hamid Reza Forootan, Mehran Peivaste, Mehrdad Hoseinpour, Nasibeh Khaleghnejad-Tabari, Arameh Abbasian, Arghavan Haj-Sheykholeslami

Background: Annually, 3-8 million infants are born with congenital anomalies worldwide, ranging from 3% to 7% of births in different countries. This study aimed to investigate the nationwide epidemiological features of birth defects in Iran.

Methods: This cross-sectional study was conducted in six major regions across Iran. The data sources were the maternity facilities affiliated with regional universities of medical sciences. All children were examined by obstetricians, pediatricians, or midwives at birth, and newborns were followed until discharge from the facility for health status, maturity, and congenital defects.

Results: A total of 138,643 births were registered in the maternity facilities across the study regions. Among these newborns, 3,458 cases were diagnosed with congenital anomalies, representing an overall prevalence rate of 249.4 per 10000 births (95% CI: 241.2-257.8). Genital organ anomalies exhibited the highest rates of defects in the country with 92.7 per 10000 births (95% CI: 86.4-98.9), followed by limb anomalies at 83.3 per 10000 births (95% CI: 77.4-89.3). The prevalence of respiratory system, chromosomal, and urinary tract anomalies was less than 10 per 10000 births.

Conclusion: Until a national registry for congenital anomalies is established, this study provides essential data on the magnitude of the health problems caused by congenital anomalies in Iran. The findings would be vital for planning and evaluating antenatal screening for birth defects, particularly for high-risk groups and regions in the country.

背景:全世界每年有 300-800 万名婴儿出生时患有先天性畸形,占不同国家新生儿的 3%-7% 不等。本研究旨在调查伊朗全国范围内出生缺陷的流行病学特征:这项横断面研究在伊朗的六个主要地区进行。数据来源是地区医科大学附属的产科机构。所有儿童在出生时均由产科医生、儿科医生或助产士进行检查,并对新生儿的健康状况、成熟度和先天性缺陷进行跟踪,直至其出院:研究地区的产科机构共登记了 138 643 例新生儿。在这些新生儿中,有 3,458 例被诊断出患有先天性畸形,总患病率为每 10000 例新生儿中有 249.4 例(95% CI:241.2-257.8)。生殖器官畸形的发病率在全国最高,每 10000 名新生儿中有 92.7 例(95% CI:86.4-98.9),其次是肢体畸形,每 10000 名新生儿中有 83.3 例(95% CI:77.4-89.3)。呼吸系统畸形、染色体畸形和泌尿系统畸形的发病率低于每万名新生儿 10 例:在建立全国先天性畸形登记册之前,这项研究提供了有关伊朗先天性畸形造成的健康问题严重程度的重要数据。研究结果对规划和评估出生缺陷产前筛查至关重要,尤其是对伊朗的高危人群和地区。
{"title":"Prevalence of Congenital Anomalies in Iran.","authors":"Ahmad Khaleghnejad-Tabari, Saeed Dastgiri, Hamid Soori, Alireza Ansari-Moghaddam, Haleh Ghaem, Mahmoud Latifi, Mohammad Reza Maracy, Saeed Aslanabadi, Fathollah Roshanzamir, Hamid Reza Forootan, Mehran Peivaste, Mehrdad Hoseinpour, Nasibeh Khaleghnejad-Tabari, Arameh Abbasian, Arghavan Haj-Sheykholeslami","doi":"10.34172/aim.31287","DOIUrl":"10.34172/aim.31287","url":null,"abstract":"<p><strong>Background: </strong>Annually, 3-8 million infants are born with congenital anomalies worldwide, ranging from 3% to 7% of births in different countries. This study aimed to investigate the nationwide epidemiological features of birth defects in Iran.</p><p><strong>Methods: </strong>This cross-sectional study was conducted in six major regions across Iran. The data sources were the maternity facilities affiliated with regional universities of medical sciences. All children were examined by obstetricians, pediatricians, or midwives at birth, and newborns were followed until discharge from the facility for health status, maturity, and congenital defects.</p><p><strong>Results: </strong>A total of 138,643 births were registered in the maternity facilities across the study regions. Among these newborns, 3,458 cases were diagnosed with congenital anomalies, representing an overall prevalence rate of 249.4 per 10000 births (95% CI: 241.2-257.8). Genital organ anomalies exhibited the highest rates of defects in the country with 92.7 per 10000 births (95% CI: 86.4-98.9), followed by limb anomalies at 83.3 per 10000 births (95% CI: 77.4-89.3). The prevalence of respiratory system, chromosomal, and urinary tract anomalies was less than 10 per 10000 births.</p><p><strong>Conclusion: </strong>Until a national registry for congenital anomalies is established, this study provides essential data on the magnitude of the health problems caused by congenital anomalies in Iran. The findings would be vital for planning and evaluating antenatal screening for birth defects, particularly for high-risk groups and regions in the country.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"27 10","pages":"545-550"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532651/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endotracheal Surfactant and Budesonide Combination Therapy in Neonatal Acute Respiratory Distress Syndrome due to Late-Onset Sepsis. 气管内表面活性物质和布地奈德联合疗法治疗晚发型败血症导致的新生儿急性呼吸窘迫综合征
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.34172/aim.31725
Asli Okbay Gunes, Aydin Bozkaya

Background: Neonatal acute respiratory distress syndrome (NARDS) is an important cause of hypoxemic respiratory failure. This study aimed to investigate the short-term effects of endotracheal surfactant and budesonide combination therapy on NARDS secondary to late-onset neonatal sepsis (LONS).

Methods: This was a retrospective, cross-sectional, and observational study. Newborns with NARDS due to LONS who received endotracheal surfactant and budesonide combination therapy between August 2022 and September 2023 were included in this study. Oxygenation status before endotracheal surfactant and budesonide treatment were compared with the values obtained two hours after treatment.

Results: Among 20 neonates, 10 (50%) were diagnosed with severe NARDS, and 10 (50%) were diagnosed with moderate NARDS. The mean corrected gestational age was 33.3±2.9 w when endotracheal surfactant and budesonide were administered to the neonates. The need for the fraction of inspired oxygen (0.75 [0.57-1.00]% vs. 0.55 [0.44-0.80]%; mean difference [MD]: 17.50%, 95% confidence interval [CI]: 14.99 to 22.50) and oxygen saturation index (OSI; 8.03 [4.98-13.94] vs. 4.71 [4.11-8.93]; MD: 2.23, 95% CI: 1.22 to 3.24) decreased (P=0.001 and P<0.001, respectively) after endotracheal surfactant and budesonide treatment. However, preductal oxygen saturation (SpO2 ; 93 [91-94]% vs. 95 [94-96]%; MD: -3.50%, 95% CI: -5.00 to -2.00) increased significantly after endotracheal surfactant and budesonide treatment when compared to pre-treatment values (P<0.001).

Conclusion: The reduction in oxygen demand and OSI, along with an increase in SpO2 after treatment compared to pre-treatment values, suggests that endotracheal surfactant and budesonide combination therapy could be an effective option to improve oxygenation in NARDS secondary to LONS.

背景:新生儿急性呼吸窘迫综合征(NARDS)是导致低氧血症性呼吸衰竭的重要原因。本研究旨在探讨气管内表面活性物质和布地奈德联合疗法对继发于晚发性新生儿败血症(LONS)的 NARDS 的短期影响:这是一项回顾性、横断面观察研究。本研究纳入了在 2022 年 8 月至 2023 年 9 月期间接受气管内表面活性物质和布地奈德联合疗法的因 LONS 导致 NARDS 的新生儿。将气管内表面活性物质和布地奈德治疗前的氧合状态与治疗两小时后的氧合状态进行比较:在 20 名新生儿中,10 名(50%)被诊断为重度 NARDS,10 名(50%)被诊断为中度 NARDS。给新生儿使用气管内表面活性物质和布地奈德时,平均矫正胎龄为 33.3±2.9 w。新生儿对吸入氧分数的需求(0.75 [0.57-1.00]% vs. 0.55 [0.44-0.80]%; 平均差异 [MD]:17.50%,95% 置信区间 [CI]:血氧饱和度指数(OSI;8.03 [4.98-13.94] vs. 4.71 [4.11-8.93];MD:2.23,95% CI:1.22-3.24)下降(P=0.001 和 P2;93 [91-94]% vs. 95 [94-96]%;MD:2.23,95% CI:1.22-3.24)。95[94-96]%;MD:-3.50%,95% CI:-5.00 至-2.00)与治疗前的值相比,气管内表面活性物质和布地奈德治疗后显著增加(P=0.001):与治疗前的数值相比,治疗后氧需求和 OSI 降低,SpO2 上升,这表明气管内表面活性物质和布地奈德联合疗法可有效改善继发于 LONS 的 NARDS 的氧合状况。
{"title":"Endotracheal Surfactant and Budesonide Combination Therapy in Neonatal Acute Respiratory Distress Syndrome due to Late-Onset Sepsis.","authors":"Asli Okbay Gunes, Aydin Bozkaya","doi":"10.34172/aim.31725","DOIUrl":"10.34172/aim.31725","url":null,"abstract":"<p><strong>Background: </strong>Neonatal acute respiratory distress syndrome (NARDS) is an important cause of hypoxemic respiratory failure. This study aimed to investigate the short-term effects of endotracheal surfactant and budesonide combination therapy on NARDS secondary to late-onset neonatal sepsis (LONS).</p><p><strong>Methods: </strong>This was a retrospective, cross-sectional, and observational study. Newborns with NARDS due to LONS who received endotracheal surfactant and budesonide combination therapy between August 2022 and September 2023 were included in this study. Oxygenation status before endotracheal surfactant and budesonide treatment were compared with the values obtained two hours after treatment.</p><p><strong>Results: </strong>Among 20 neonates, 10 (50%) were diagnosed with severe NARDS, and 10 (50%) were diagnosed with moderate NARDS. The mean corrected gestational age was 33.3±2.9 w when endotracheal surfactant and budesonide were administered to the neonates. The need for the fraction of inspired oxygen (0.75 [0.57-1.00]% vs. 0.55 [0.44-0.80]%; mean difference [MD]: 17.50%, 95% confidence interval [CI]: 14.99 to 22.50) and oxygen saturation index (OSI; 8.03 [4.98-13.94] vs. 4.71 [4.11-8.93]; MD: 2.23, 95% CI: 1.22 to 3.24) decreased (<i>P</i>=0.001 and <i>P</i><0.001, respectively) after endotracheal surfactant and budesonide treatment. However, preductal oxygen saturation (SpO<sub>2</sub> ; 93 [91-94]% vs. 95 [94-96]%; MD: -3.50%, 95% CI: -5.00 to -2.00) increased significantly after endotracheal surfactant and budesonide treatment when compared to pre-treatment values (<i>P</i><0.001).</p><p><strong>Conclusion: </strong>The reduction in oxygen demand and OSI, along with an increase in SpO<sub>2</sub> after treatment compared to pre-treatment values, suggests that endotracheal surfactant and budesonide combination therapy could be an effective option to improve oxygenation in NARDS secondary to LONS.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"27 10","pages":"573-579"},"PeriodicalIF":1.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532653/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges and Weaknesses of Leadership and Governance-related Health Policies in Iran: A Systematic Review. 伊朗与领导力和治理有关的卫生政策面临的挑战和薄弱环节:系统回顾。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.34172/aim.28907
Rahim Khodayari-Zarnaq, Khorshid Mobasseri, Shabnam Ghasemyani, Fatemeh Sadeghi-Ghyassi, Maryam Naghshi, Neda Kabiri

Background: A better understanding of health system performance requires evaluating achievements and challenges, thereby providing a basis for effective reforms. This systematic review aims to investigate the challenges and weaknesses of leadership and governance-related health policies in Iran.

Methods: In this qualitative systematic review, we followed the instructions of the Joanna Briggs Institute (JBI). It encompassed qualitative studies assessing challenges and weaknesses of leadership and governance-related health policies. Thematic synthesis was conducted in three stages to identify common themes.

Results: The primary database search yielded 1890 records, of which 152 were fully assessed, resulting in the inclusion of 57 studies in this review. Thematic synthesis produced 157 structured codes and identified 11 main descriptive themes of challenges in leadership and governance-related health policies. These themes included hospital autonomy policy, challenges to the entire health system, governance of medical universities, healthcare payment systems, sustainable universal health insurance coverage, informal payments, insurance systems, induced demand, strategic purchasing of health services, the family physician program, family physician and rural health insurance programs, and primary healthcare human resources.

Conclusion: The identified challenges underscore the urgent need for strategic reforms and interventions to overcome the complex issues plaguing the healthcare system. By addressing these challenges, policymakers and top healthcare managers might ensure that the population have access to high-quality care in a more responsive healthcare system.

背景:要更好地了解卫生系统的绩效,就必须评估所取得的成就和面临的挑战,从而为有效改革奠定基础。本系统综述旨在调查伊朗与领导力和治理相关的卫生政策所面临的挑战和存在的不足:在这一定性系统综述中,我们遵循了乔安娜-布里格斯研究所(JBI)的指示。方法:在这一定性系统综述中,我们遵循了乔安娜-布里格斯研究所(JBI)的指示,对领导力和治理相关卫生政策所面临的挑战和薄弱环节进行了定性评估。专题综述分三个阶段进行,以确定共同的主题:主要数据库搜索共获得 1890 条记录,其中 152 条经过全面评估,最终有 57 项研究被纳入本综述。专题综述产生了 157 个结构化代码,并确定了领导力和治理相关卫生政策挑战的 11 个主要描述性主题。这些主题包括医院自治政策、整个医疗系统面临的挑战、医科大学的管理、医疗支付系统、可持续的全民医疗保险覆盖、非正式支付、保险系统、诱导需求、医疗服务战略采购、家庭医生计划、家庭医生和农村医疗保险计划以及初级医疗人力资源:已确定的挑战突出表明,迫切需要进行战略性改革和干预,以克服困扰医疗保健系统的复杂问题。通过应对这些挑战,政策制定者和医疗保健高层管理者可以确保民众在一个反应更迅速的医疗保健系统中获得高质量的医疗服务。
{"title":"Challenges and Weaknesses of Leadership and Governance-related Health Policies in Iran: A Systematic Review.","authors":"Rahim Khodayari-Zarnaq, Khorshid Mobasseri, Shabnam Ghasemyani, Fatemeh Sadeghi-Ghyassi, Maryam Naghshi, Neda Kabiri","doi":"10.34172/aim.28907","DOIUrl":"10.34172/aim.28907","url":null,"abstract":"<p><strong>Background: </strong>A better understanding of health system performance requires evaluating achievements and challenges, thereby providing a basis for effective reforms. This systematic review aims to investigate the challenges and weaknesses of leadership and governance-related health policies in Iran.</p><p><strong>Methods: </strong>In this qualitative systematic review, we followed the instructions of the Joanna Briggs Institute (JBI). It encompassed qualitative studies assessing challenges and weaknesses of leadership and governance-related health policies. Thematic synthesis was conducted in three stages to identify common themes.</p><p><strong>Results: </strong>The primary database search yielded 1890 records, of which 152 were fully assessed, resulting in the inclusion of 57 studies in this review. Thematic synthesis produced 157 structured codes and identified 11 main descriptive themes of challenges in leadership and governance-related health policies. These themes included hospital autonomy policy, challenges to the entire health system, governance of medical universities, healthcare payment systems, sustainable universal health insurance coverage, informal payments, insurance systems, induced demand, strategic purchasing of health services, the family physician program, family physician and rural health insurance programs, and primary healthcare human resources.</p><p><strong>Conclusion: </strong>The identified challenges underscore the urgent need for strategic reforms and interventions to overcome the complex issues plaguing the healthcare system. By addressing these challenges, policymakers and top healthcare managers might ensure that the population have access to high-quality care in a more responsive healthcare system.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"27 9","pages":"508-521"},"PeriodicalIF":1.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11496596/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortality Rate and Years of Life Lost Due to Ischemic Heart Disease in Southern Iran between 2004 and 2019: A Population-Based Study. 2004 年至 2019 年伊朗南部缺血性心脏病死亡率和寿命损失年数:一项基于人口的研究。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.34172/aim.28159
Mohammad Hossein Sharifi, Alireza Mirahmadizadeh, Jafar Hassanzadeh, Hamed Bazrafshan Drissi, Habibollah Azarbakhsh

Background: Cardiovascular diseases (CVDs) account for one-third of all deaths worldwide.

Methods: In this cross-sectional study, we extracted all death records from the Electronic Death Registration System categorized as ischemic heart disease (IHD) based on age, gender, and the year of death according to ICD-10 for this cross-sectional analysis. The Fars province is situated in southern Iran with a population of about 4 million. An analysis of years of life lost (YLL) resulting from premature death from IHD was conducted using the World Health Organization's 2015 YLL framework. The trend of the YLL rates was investigated using joinpoint regression.

Results: In the Fars province, IHD was the cause of 46969 deaths throughout a 16-year study period, (2004 to 2019). Among these, 26,503 (56.4%) were men. The crude death rates per 100000 population for men and women were 84.2 and 66.5, respectively. The total YLL due to premature death due to IHD, during the 16-year study period, was 287625 in male, 209665 in female. The joinpoint regression showed a declining trend in the YLL rate associated with premature death. Annual Percent Change (APC) was -0.6% (95% CI -6.9 to 6.1, P=0.851) for males and -1.5% (95% CI -5.2 to 2.2, P=0.418) for females.

Conclusion: The trends of the standardized mortality rate, YLL, and crude mortality rate held steady throughout a 16-year period. Planning for comprehensive primary and secondary prevention and increasing public knowledge of IHD are necessary.

背景:心血管疾病(CVD)占全球死亡人数的三分之一:心血管疾病占全球死亡人数的三分之一:在这项横断面研究中,我们从电子死亡登记系统中提取了根据年龄、性别和死亡年份归类为缺血性心脏病(IHD)的所有死亡记录,并根据 ICD-10 进行了横断面分析。法尔斯省位于伊朗南部,人口约 400 万。我们采用世界卫生组织 2015 年 "生命损失年 "框架,对因心脏病过早死亡而造成的生命损失年数(YLL)进行了分析。结果显示:在法尔斯省,因心肌梗死而过早死亡的人口比例为 1:1,因心肌梗死而过早死亡的人口比例为 2:1:在为期 16 年的研究期间(2004 年至 2019 年),法尔斯省共有 46969 人死于 IHD。其中,26503 人(56.4%)为男性。男性和女性每 10 万人的粗死亡率分别为 84.2 和 66.5。在 16 年的研究期间,男性因心肌梗死过早死亡的总年均死亡率为 287625 例,女性为 209665 例。连接点回归显示,与过早死亡相关的年致死率呈下降趋势。男性的年百分比变化(APC)为-0.6%(95% CI -6.9至6.1,P=0.851),女性为-1.5%(95% CI -5.2至2.2,P=0.418):结论:在16年的时间里,标准化死亡率、YLL和粗死亡率的趋势保持稳定。有必要制定全面的一级和二级预防计划,并提高公众对心肌缺血的认识。
{"title":"Mortality Rate and Years of Life Lost Due to Ischemic Heart Disease in Southern Iran between 2004 and 2019: A Population-Based Study.","authors":"Mohammad Hossein Sharifi, Alireza Mirahmadizadeh, Jafar Hassanzadeh, Hamed Bazrafshan Drissi, Habibollah Azarbakhsh","doi":"10.34172/aim.28159","DOIUrl":"10.34172/aim.28159","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular diseases (CVDs) account for one-third of all deaths worldwide.</p><p><strong>Methods: </strong>In this cross-sectional study, we extracted all death records from the Electronic Death Registration System categorized as ischemic heart disease (IHD) based on age, gender, and the year of death according to ICD-10 for this cross-sectional analysis. The Fars province is situated in southern Iran with a population of about 4 million. An analysis of years of life lost (YLL) resulting from premature death from IHD was conducted using the World Health Organization's 2015 YLL framework. The trend of the YLL rates was investigated using joinpoint regression.</p><p><strong>Results: </strong>In the Fars province, IHD was the cause of 46969 deaths throughout a 16-year study period, (2004 to 2019). Among these, 26,503 (56.4%) were men. The crude death rates per 100000 population for men and women were 84.2 and 66.5, respectively. The total YLL due to premature death due to IHD, during the 16-year study period, was 287625 in male, 209665 in female. The joinpoint regression showed a declining trend in the YLL rate associated with premature death. Annual Percent Change (APC) was -0.6% (95% CI -6.9 to 6.1, <i>P</i>=0.851) for males and -1.5% (95% CI -5.2 to 2.2, <i>P</i>=0.418) for females.</p><p><strong>Conclusion: </strong>The trends of the standardized mortality rate, YLL, and crude mortality rate held steady throughout a 16-year period. Planning for comprehensive primary and secondary prevention and increasing public knowledge of IHD are necessary.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"27 9","pages":"494-500"},"PeriodicalIF":1.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11496604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archives of Iranian Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1